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Significance of this study 
What is already known on this subject? 
• Chromosomal instability (CIN), is a major hallmark of hepatic tumorigenesis and 
hampers prognosis and therapy. The underlying mechanisms are not well 
characterized. 
• CIN is regarded as an ongoing elevated frequency of mitotic errors that leads to 
numerical and structural chromosome aberrations in a significant proportion of 
cell divisions leading to intra-tumoral heterogeneity and drug resistance. 
• DNA damag  caused by genotoxic agents activates DNA damage response 
checkpoint kinase 2 (Chk2)  protein expression 
• Mislocalization of proteins, including oncoproteins, tumor suppressors, and other 
cancer-related proteins, can interfere with normal cellular function and 
cooperatively drive tumor development 
 
What are the new findings? 
• Mitotic errors  represented by lagging chromosomes cause DNA damage and  
overexpress   Chk2  throughout hepatic tumorigenesis  
•  Chk2  and the activation/phosphorylated forms of Chk2 mislocalize within the 
mitotic structures in the presence of DNA damage contributing to increased 
numbers of cells with lagging chromosomes. In contrast, knockdown of Chk2 
reduces  the number of cells with lagging chromosomes  and the mitotic index  
• The Chk2 forkhead-associated domain (FHA) is responsible for the 
mislocalization of the protein at the mitotic structures  
• Chk2 is expressed at the nuclear level in a subset of human HCC  and this 
aspect correlates with HCC progression. Moreover, CHK2 expression is 
significantly higher in HCC patients with mutated TP53, a hallmark of genomic 
instability, than in those with mutated CTNNB1/beta-catenin. 
How might it impact on clinical practice in the foreseeable future? 
• The study reveals a new mechanistic insight in the co-involvement of Chk2 in 
CIN i.e. Chk2 mislocalization, hence indicating the possibility to use Chk2 as a 
new drug target in HCC 
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• The findings of this study suggest Chk2 as a putative biomarker that can be used 
to detect DNA damage and  chromosomal instability in HCC providing a valuable 
support, not only for prognosis, but also for identifying patients who are likely to 
have a response to therapy.  
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ABSTRACT 
Objective 
Chromosomal instability (CIN) is the most common form of genomic instability, that 
promotes hepatocellular carcinoma (HCC) progression by enhancing tumour 
heterogeneity, drug resistance and immunity escape. CIN per se is an important factor 
of DNA damage, sustaining structural chromosome abnormalities   but the underlying 
mechanisms are unknown. 
Design 
DNA-damage response protein  Chk2  expression was evaluated in an animal model of 
diethylnitrosamine-induced HCC characterized by DNA damage and elevated mitotic 
errors. Chk2  was also determined in two  discrete cohorts of human HCC specimens. 
To assess the functional role of Chk2, gain on- and loss-of-function, mutagenesis, 
karyotyping, and immunofluorescence/live imaging were performed by using HCT116, 
Huh7 and human hepatocytes immortalized with hTERT gene (HuS). 
Results 
We demonstrate that mitotic errors during HCC tumorigenesis cause lagging 
chromosomes/DNA damage and activation of Chk2. Overexpression/phosphorylation 
and   mislocalization within the mitotic spindle  of  Chk2   contributes to induce  lagging  
chromosomes. Lagging chromosomes and mitotic activity are reversed by knockdown 
of Chk2. Furthermore,  up-regulated Chk2 maintains  mitotic activity interacting with 
Aurora B kinase for chromosome condensation and cytokinesis. The forkhead-
associated (FHA) domain of Chk2 is required for Chk2  mislocalization to mitotic 
structures. In addition, retinoblastoma  protein phosphorylation contributes to defective 
mitoses. A cohort  and independent validation cohort show a strong cytoplasm-to 
nuclear Chk2  translocation in a subset of  HCC patients. 
Conclusions 
The study reveals a new mechanistic insight in the co-involvement of Chk2 in HCC 
progression. These findings propose Chk2 as a putative biomarker to detect CIN in 
HCC providing a valuable support for clinical/therapeutical management of patients. 
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Introduction 
Hepatocellular carcinoma (HCC) is the primary malignancy of hepatocytes and the most 
frequent solid tumour of the liver. Half a million cases occur annually and the World 
Health Organization has recently ranked HCC as the second most lethal cancer 
worldwide [1]. Different etiological factors such as hepatitis B and C virus, alcohol and 
diabetes cause liver injury followed by inflammation, necrosis and hepatocytes 
proliferation [2]. Continuous cycles of this destructive–regenerative process culminates 
in liver cirrhosis which is characterized by regenerating nodules that progress to 
dysplastic nodules and ultimately HCC [3,4]. More than 90% of HCC, including 
dysplastic nodules in cirrhotic liver, possess chromosomal aberrations suggesting that 
chromosomal defects occur at early stages of tumour development and several 
attempts have been made to connect different chromosomal aberration patterns as 
specific subsets of HCC, albeit with limited success [5-7]. A common feature of human 
HCC and dysplastic nodules is represented by chromosomal instability (CIN). Various 
types of chromosomal aberrations, including numerical (aneuploidy) and structural (e.g., 
translocations, deletions), are found in HCC and are linked to tumorigenesis [8,9]. An 
important aspect in studying HCC tumorigenesis is to distinguish between the state of 
the karyotype, and the rate of karyotypic change. In fact, aneuploidy is not synonymous 
with CIN, because  aneuploid tumours are stable  with uniform karyotype and 
phenotype [10-12]. Conversely,  there is an  increased rate of CIN generating  diverse 
karyotypes within the same  tumour. This  yields a heterogeneous tumour cell 
population that has the ability to undergo selective evolution in term of drug resistance 
and  immune system escape mechanisms [13-15]. CIN is regarded as an ongoing 
elevated frequency of mitotic errors that leads to additional chromosome gains or losses 
in a significant proportion of cell divisions. Our hypothesis is that CIN per se is also an 
important mechanism of DNA damage inducing  structural chromosome aberrations in 
HCC. To verify this hypothesis we utilized   checkpoint kinase 2 (Chk2) as a central 
effector of the cell response to DNA damage. In fact,  Chk2 has been described   to 
detect a variety of DNA lesions  caused by exogenous and endogenous genotoxic 
agents. Our aim is   to investigate the expression of this kinase in hepatic 
carcinogenesis and its correlation with the genesis of structural chromosomal 
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aberrations. Here, we provide evidence that  defective chromosome segregation i.e.  
lagging chromosomes causes DNA damage and determines an 
overexpression/phosphorylation  of Chk2. Furthermore,  the  mislocalization of Chk2 
with components of the mitotic spindle  contributes to chromosome missegregations. 
These data are  corroborated with the observation of an increased Chk2 and nuclear 
translocation in two independent cohorts of human HCC specimens.  
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Materials and Methods 
Please refer to the Supplementary Materials and Methods  for more detailed 
descriptions. 
 
Tissue Samples and Immunohistochemistry Assays. 
Florence cohort, University Hospital of Florence; formalin-fixed, paraffin-embedded 
tissue were obtained from an archive of liver biopsies of patients diagnosed with  HCC.  
H&E-stained tissue sections of 49 patients  were reviewed, and areas of cirrhotic and 
HCC were identified.  Chk2 antigen retrieval was performed by heating in citrate buffer 
pH 6.0 at 98°C for 30 minutes. Non-specific signal was eliminated by peroxidase block 
for 10 minutes at RT. Primary antibody was incubated at room temperature overnight in 
a humidified chamber followed by HRP-conjugated secondary antibody incubation for 
30 minutes at room temperature. Antibody binding was revealed by DAB and reaction 
was stopped by immersion of tissue sections in distilled water once brown colour 
appeared. Tissue sections were counterstained by hematoxylin, dehydrated in graded 
ethanols and mounted. All reagents for immunohistochemistry were from Dako. 
Appropriate positive and negative controls were included for each run of 
immunohistochemistry. Chk2 expression was determined according to H-score method. 
For H-score assessment, 10 fields were chosen at random at x400 magnification and 
the staining intensity in the malignant cell nuclei was scored as 0, 1, 2, and 3 
corresponding to the presence of negative, weak, intermediate, and strong brown 
staining, respectively. The total number of cells in each field and the number of cells 
stained at each intensity were counted. The average percentage positive was 
calculated, and a H-score between 0 and 300 was obtained where 300 was equal to 
100% of tumor cells stained brown strongly. The positive cut off was considered ≥100 
(supplemental Figure S1). Chk2 expression in biopsy sections was scored by a 
pathologist and two researchers independently. 
London cohort, Royal Free Hospital; formalin-fixed, paraffin-embedded surgical 
specimens from consecutive  patients diagnosed with  HCC were retrieved from Royal 
Free Hospital archives. All samples were stained with H&E and the sections were 
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reviewed and suitable areas of cirrhosis and HCC were identified in 20 samples. 
Antigen retrieval was performed by microwaving (720W) in pH 6.0 sodium citrate buffer 
for 30 mins. Endogenous peroxidase and non-specific binding of primary antibody was 
blocked. The primary Chk2 antibody was incubated at overnight at 5°C. Primary  
antibody detection was carried out using the Novolink polymer detection system 
(Novocastra).Tissue sections were counterstained with Mayer’s hematoxylin. 
 
Experimental hepatocarcinogenesis.Twenty-five female Wistar rats (210-225 g) were 
given diethylnitrosamine 50 mg/L ad libitum in their drinking water for a period of 10 
weeks as previously described [16]. Another group of five animals were maintained as 
controls. All animals were administered a standard laboratory diet and were weighed 
each week. Five animals for each time point were sacrificed on week 4, 6, 8, 10 and, 
14.Tumours and liver tissues were removed and fixed in 10% neutral buffered formalin. 
Liver sections (5µm)   were cut from paraffin-embedded blocks and stained Chk2 
(Abcam, #ab47433), phospho-Histone H2A.X (Cell Signaling, #9718)  and hematoxylin 
and eosin (H&E) for histological examination and expression were determined 
according to H-score method. 
 
CHK2 Expression in HCC samples from Cancer Genome Atlas (TCGA) database. 
The TCGA-LIHC cohort, containing 377 cases, was used to validate CHK2 expression 
levels in distinct subtypes of HCC. The TCGA database (https://gdc-portal.nci.nih.gov) 
was accessed on November 16, 2016 through the cGbioportal website 
(http://www.cbioportal.org/) to retrieve patients with either TP53 or CTNNB1 mutation. 
The TCGA_participant_barcode was used to download CHK2 expression from RNA-seq 
data using the firebrowse portal (http://firebrowse.org). Patients with co-occurrent 
mutations of TP53 and CTNNB1 were excluded from the analysis. CHK2 expression 
levels were retrieved for 101 patients with TP53 mutation and 85 patients with CTNNB1 
mutation. Statistical analysis was performed  using the Mann-Whitney test with 
GraphPad 6 software. 
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Results  
 
Chk2 is overexpressed in a subset of human HCC 
To test our hypothesis that hepatic tumorigenesis per se could be a cause of DNA 
damage and structural chromosome aberrations, an animal model of diethylnitrosamine-
induced HCC was employed which induced macroscopical visible tumours after 14 
weeks (Figure 1A).This model has previously been established to induce elevated 
mitotic errors, DNA damage and chromosome aberrations [17]. Using this model we can 
compare the expression levels of DNA damage response proteins induced by the 
genotoxic activity of diethylnitrosamine with a later phase represented exclusively by 
tumorigenesis. Therefore, Chk2, a DNA damage-response checkpoint kinase,  and 
phospho-Histone H2A.X (Ser139) a component of chromatin which becomes 
phosphorylated following DNA damage (e.g. DNA double-stranded breaks)  were 
investigated [18].   As shown in Figure 1B several nuclei of cancer cells exhibited an 
increased expression of Chk2  and phospho-Histone H2A.X  revealing the presence of 
DNA damage.  A timeline analysis of liver sections demonstrated  a two-fold increase in 
Chk2 basal levels at 4 weeks followed by decreased values after 8 weeks (Figure 1C). 
In contrast, by 14 weeks tumours were macroscopically visible and histologically evident 
in 80% of animals. Immunostaining of HCC sections showed a significant increased 
expression of Chk2 and phospho-Histone H2A.X (Figure 1C and 1D) when compared 
with liver sections without evidence of tumours (8 weeks). Taken together, these data 
showed that the increased expression of Chk2 reflected a response triggered by DNA 
damage during tumorigenesis. 
To extend these findings to humans, the expression of Chk2 in patients with cirrhotic-
related HCC and normal liver was examined in liver biopsies from hospital archives 
(Florence cohort, supplemental Table 1). A nuclear staining of Chk2 was detectable in 
distinctive histotypes of HCC (supplemental   Figure S2 and  S3). More specifically, the 
expression level of Chk2 in different grades of HCC was evaluated. Remarkably, within 
histological grade II and III, significant quantitative differences between positive and 
negative Chk2 patients were found (p<0.001). Overall, these data demonstrated that 
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Chk2 nuclear positivity was found in 63.2% (31 of 49) of HCCs analyzed (supplemental  
Table 2 ). A separate validation cohort of patients was examined at Royal Free Hospital, 
London (supplemental Table 3). Normal liver tissue showed a moderate and diffuse 
cytoplasmic staining, whereas Grade 1 specimens were characterized with weak focal 
cytoplasmic Chk2 staining. In Grade 2, a Chk2 perinuclear and nuclear accumulation 
was observed.  Specimens with Grade 3 showed exclusively a clear and strong nuclear 
staining, without cytoplasmic and perinuclear Chk2 staining (Figure 2a and 
supplemental Table 4). Furthermore, the expression levels of CHK2 were analyzed in a 
public available cohort of HCC from the TCGA database. We found a highly-significant 
increase of CHK2 expression in HCC with mutated TP53, a hallmark of genomic 
instability, with respect to those with CTNNB1/beta-catenin mutation (Figure 2b).  
 
 
Defective chromosome segregations cause DNA damage  
The previous observations prompted us to investigate the functional role of Chk2.  For 
this reason, three different cell lines were employed. The colon carcinoma cell line 
HCT116 was used i.e. a near-diploid cell line that faithfully segregates chromosomes to 
maintain a stable karyotype and is commonly employed in CIN studies [19,20]. 
Secondly, the HCC cell line Huh7 was used which is a stable hyperdiploid karyotype 
with altered chromosomal structures and finally HuS cells were used marked with an 
unstable karyotype [21]. HuS cells are human hepatocytes immortalized with human 
telomerase reverse transcriptase (hTERT), a gene described commonly activated in 
human HCC [8, 9]. HuS cells just established in culture (0 generation) and hereafter 
referred to as HuS0gen showed a karyotype with a distribution of 46 chromosomes 
(Figure 3A) and expressed low levels of Chk2 protein in comparison to HCT116 and 
Huh7 (Figure 3B). The HuS0gen cells were maintained in culture and after 30 
consecutive generations (HuS30gen) were re-examined to verify the karyotype status. 
The cells showed a distribution near-triploid, with many structural chromosomal defects 
(Figure 3C and supplemental Figure S4A)  and importantly  this aspect was associated 
with increased expression of Chk2 protein, (Figure 3B). Likewise  with the murine  
model, we evaluated the expression levels of phospho-Histone H2A.X (Ser139) in all 
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the cell lines studied. As shown in Figure 3D, both HuS0gen and HuS30gen cells 
exhibited high levels of phospho-Histone H2A.X, although with different levels of 
expression. These findings indicate the presence of DNA double-strand breaks, a 
hallmark of DNA damage, in HuS cells.  
  
Overexpressed Chk2 mislocalizes with mitotic structures in HuS30gen cells but 
not in HCT116 and Huh7.  
The finding of overexpressed Chk2 in both karyotyped stable HCT116 and Huh7 and  in 
unstable karyotyped HuS30gen did not demonstrate a specific role for Chk2 in defective 
chromosome segregation. Therefore, we analyzed the cell lines HCT116, Huh7, 
HuS0gen and HuS30gen by immunofluorescence to examine a possible altered 
localization of Chk2 with the mitotic structures. Chk2  showed a  localization to the 
spindle poles of metaphase mitotic structures in HCT116, Huh7, and HuS0gen (Figure 
4A).   Very importantly, HuS30gen cells showed a robust localization of Chk2  with all  
metaphase mitotic structures indicating a clear mislocalization of Chk2  (Figure 4A and 
supplemental Figure S4B). These results suggest that in  HuS0gen cells, expressing 
low levels of DNA damage,  Chk2 weakly co-localized with the mitotic spindle 
components, whereas  Chk2 is increased and strongly associated with all mitotic 
structures in HuS30gen cells  that are expressing high levels of DNA damage. To 
further address these findings  we stably transfected HuS0gen with HA-tagged Chk2,   
HuS0gen overexpressing Chk2  exhibited    Chk2  localization  with mitotic structures as 
shown in Figure 4B. Next, we measured the number of  lagging chromosomes (Figure 
4C) in HuS0gen, HuS30gen, and in HuS0gen stably transfected with HA-tagged Chk2 
to mimic overexpression of Chk2. As shown in Figure 4D, overexpression of Chk2 
significantly correlated with high number of mitoses with lagging chromosomes in 
HuS30gen, and in HuS0gen overexpressing HA-tagged Chk2. These data clearly 
indicate that indeed overexpression and mislocalization  of Chk2 itself contributes to 
defective chromosome segregations. Furthermore,  to assess that the increased 
expression of Chk2 was  specifically  related to those  mitoses with defective 
chromosome segregations   and not  a random  deregulation of proteins, the expression 
of Nek2 (NIMA related kinase 2)  protein was evaluated. Nek2 is a protein located at the 
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centrosome/spindle poles and responsible for chromosomal defective segregations [22]. 
HCT116 and Huh7 cells showed a strong Nek2 expression whereas both HuS0gen and 
HuS30gen cells expressed low levels of Nek2 (supplemental Figure S5) suggesting that 
the previously observed  overexpression of Chk2 in Hus30gen was a specific event that 
coincided with structural chromosomal defects and DNA damage.  
 
 
Chk2 overexpression is correlated with increased  chromosomal missegregations  
The    findings  that  HuS30gen express high levels of Chk2 protein   correlating  with 
DNA damage (Figure 3B and 3D), prompted us to  investigate the effects of knocking 
down expression of CHK2 in HuS30gen cells by retroviral-mediated short hairpin RNA 
(shRNA) transduction. A pool of four shRNA targeting Chk2 resulted in effective 
decrease of the protein (Figure 5A). It is important to note that silencing CHK2 coincided 
with a significant reduction of  the number of HuS30gen cells with lagging chromosomes  
and HuS30gen mitotic index.  To address any off target effects of the hairpins, we 
rescued the mitotic index and the number of cell with lagging chromosomes of the 
knockdown HuS30gen by expressing a myc-tagged version of Chk2 that circumvents 
the shRNA directed against human Chk2 (Figure 5B and 5C). These data demonstrate 
that Chk2 overexpression is correlated with increased  chromosomal missegregation 
and mitotic index. 
 
 
Defective mitoses-related DNA damage promotes Chk2 phosphorylation and 
mislocalization within mitotic structures. 
Human CHK2, is a 543 amino acid protein that consists of a N-terminal SQ/TQ cluster 
domain (SCD), a central forkhead-associated (FHA) domain, and a C-terminal 
serine/threonine kinase domain [23]. The SCD consists of multiple SQ/TQ (Ser-Gln/Thr-
Gln) motifs with Thr68 being the primary site to be phosphorylated in response to DNA 
damage followed by phosphorylation of Thr387 in the activation loop of the kinase 
domain [24, 25]. Therefore, the  protein expression of phospho-Thr68-Chk2 and 
phospho-Thr387-Chk2 in HuS30gen and HuS0gen stably transfected with HA-tagged 
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Chk2 were assessed. As shown in Figure 5D phospho-Thr68-Chk2 and phospho-
Thr387-Chk2 were highly expressed in HuS30gen and in HuS0gen stably transfected 
with HA-Chk2, but not in HuS0gen as expected. Furthermore, phospho-Thr68-Chk2 
revealed a robust localization with components of the mitotic spindle as previously  
shown for Chk2. In particular, a prominent association of phospho-Thr68-Chk2 was 
observed with mitotic structures such as the spindle poles, kinetochores and midbody in 
Hus30gen cells, (Figure 5E, upper panels). In contrast, Huh7 cells  expressing   low 
levels of DNA damage ( see Figure 3D)  did not  show co-localization of phospho-
Thr68-Chk2 with mitotic structures, (Figure 5E, lower panels). Taken together, these 
results reveal an overexpression/mislocalization of phosphorylated Chk2,  which is 
correlated with its activation status, and manifestations of lagging chromosomes-
induced DNA damage. 
 
 
Up-regulated Chk2 cooperates with Aurora B for chromosome condensation and 
cytokinesis. 
As previously shown the typical localization of activated Chk2 in HuS30gen cells was 
observed in kinetochores and specifically the midbody, suggesting a possible interaction 
with Aurora B kinase. This protein is known to be involved in chromosome 
condensation, the assembly of the spindle midzone in anaphase and the midbody 
during telophase. Furthermore, Aurora B kinase has been identified as an effective 
predictor of aggressive HCC recurrence, in relation to genomic instability [26]. 
Therefore, HuS0gen cells were transfected with HA-tagged Chk2 and 
immunofluorescence analyses revealed a co-localization of Chk2 with Aurora B 
throughout all mitotic phases, and this co-localization was also present in cells marked 
with lagging chromosomes (Figure 6A and 6B). Aurora B is responsible for the 
phosphorylation of histone H3 (pHH3),  and pHH3 serine residue (Ser-10) is considered 
to be a crucial event for the onset of mitosis. The utility of pHH3 to identify mitoses has 
been demonstrated in several cancer studies [27-29]. As, the co-localization of Aurora B 
with Chk2 was demonstrated we further explored the co-localization of overexpressed 
HA-Chk2 with pHH3. As shown in Figure 6C, Chk2 exhibited a striking co-localization 
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with pHH3. Overall, the data so far demonstrate that in  unstable HuS cells during 
mitosis, lagging chromosomes cause DNA damage,  overexpression  of Chk2 which 
localizes to all mitotic structures. This overexpressed and mislocalized Chk2 protein 
contributes to a constant mitotic activity and more important Aurora B kinase and pHH3 
interact with Chk2. This favours a possible scenario where an overexpressed and 
mislocated Chk2 overrules the signalling specificity at distinct mitotic checkpoints 
inducing itself chromosomal aberrations, hence CIN. 
 
The forkhead associated domain (FHA) determines Chk2 mislocalization to 
mitotic structures and is essential for DNA damage response 
To understand how Chk2 is recruited to the mitotic structures in such a specific manner, 
we investigated Chk2 specific domain(s) that are  required for Chk2 localization.  A 
series of RFP-tagged Chk2 variants were created, each  variant carrying a point 
mutation or a deletion, and were expressed and localized individually in HuS30gen. The 
RFP-Chk2D347A, a kinase-inactive mutant, localized similarly as shown for RFP-Chk2 
(Figure 7A). This indicated  that the kinase activity is dispensable for Chk2 
mislocalization (Figure 7B). The FHA domain of Chk2 has been proposed to mediate 
localization of Chk2 to mitotic structures for the reason that FHA domains function as 
phospho-threonine-binding protein motifs. The deletion of the Chk2 FHA domain 
disrupted the localization of the protein to mitotic structures such as the spindle poles 
and kinetochores indicating that the deletion of the FHA is responsible for the observed 
mislocalization (Figure 7C). Indeed, the entire FHA domain RFP-tagged localized to 
mitotic structures similar to RFP-Chk2 (Figure 7D). Along these lines, we can conclude 
that the FHA domain is required for proper Chk2 localization to mitotic structures. 
Furthermore, we analyzed the effects of the several Chk2 mutants on lagging 
chromosomes. Interestingly, transfection of HuS0gen with Chk2 FHA domain   
significantly reduced  the number of lagging chromosomes (Figure 7E). This result 
suggests  a dominant negative effect of  Chk2 FHA domain   towards  endogenous 
Chk2. 
 
Rb phosphorylation contributes to defective mitoses in HuS cells. 
Page 14 of 79
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
15 
 
An important point raised by defective mitoses-related DNA damage as observed in this 
study is why the cells do not sense signals deployed to curb cell proliferation, as 
normally the growth of cultured diploid cells is halted by chromosome missegregation. In 
HCC, p53 deficiency has been described to participate in the development of CIN, 
however the relevance of p53 to HCC initiation, progression, or both, remains an area of 
active investigation [2]. Therefore, the basal level of p53 in HCT116, Huh7, HuS30gen 
and HuS0gen was investigated. As shown in Figure 8A, p53 was expressed in Huh7 
and at  low level in HuS30gen cells. HuS0gen cells did not  express p53 in basal 
conditions, however   treatment of the cells  with   5-fluorouracil, a DNA-damaging 
agent,  triggered a strong  p53 protein expression. Based on these findings  we assume  
that  p53 expression  may   be a late event  in  HuS cells, as  a result of several  
defective mitoses [19].  Furthermore, mutated p53 was not present in HCT116 and 
HuS30gen cells in contrast to Huh7 cells that  we used as a positive control (Figure 8B) 
[30]. 
 The possible involvement of the retinoblastoma protein Rb was evaluated since several 
studies have described Rb as an important regulator of cell division [31]. Specifically, 
Rb phosphorylation determines Rb inactivation and leads to defective mitoses [31]. 
Therefore, we evaluated the protein expression levels of phospho-Rb (Ser807/811) in  
HCT116, HuS0gen cells and  HuS30gen. As shown in Figure 8C  HuS30gen cells 
express higher levels of phospho-Rb (Ser807/811) in comparison to HuS0gen cells. 
Moreover, HCT116 (Figure 8D), HuS30gen (Figure 8E) and HuS0gen (Figure 8F) 
exhibited a localization of phospho-Rb (Ser807/811) at the chromosomal level. Taken 
together, these findings suggest that in HuS30gen Rb phosphorylation is required to 
sustain mitotic activity which leads to mitotic defects and DNA damage.  
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Discussion 
The neoplastic evolution of HCC proceeds through a multi-step histological process that 
is less well defined than that of other cancer types. Hyperplastic nodules of regenerating 
hepatocytes have normal karyotype and represent a potential first step towards HCC. 
These lesions can progress to dysplastic nodules, which have abnormal chromosome 
features including numerical and structural alterations. These dysplastic nodules can 
evolve to HCC marked  with recurrent regions of copy number change and allelic 
imbalances [3, 4].  Loss of certain tumour suppressors or gain of specific oncogenes 
promote cell division as shown in many previous studies  [25, 32]. We demonstrate  that 
this coincides  with defective mitoses which can cause DNA damage. This scenario is 
conceivable considering that massive deregulation of mitosis is incompatible with cell 
survival and can even be tumour suppressive [33]. Therefore, subtle rather than 
massive mitotic defects are expected to underlie CIN in HCC, allowing a tolerable level 
of chromosome defects. To support this view we have provided  evidence in this study 
that hepatocarcinogenesis with  lagging chromosomes elicits the expression of DNA 
damage response protein Chk2. Thus,  the overexpression of Chk2 and its 
mislocalization within structures of   the mitotic spindle contribute to sustain cell division 
and chromosomes missegregation [34-36]. This forms a self-perpetuating mechanism 
causing  DNA damage (Figure 9).  
 We have also found that functional Rb inactivation is necessary but not sufficient to 
trigger chromosome missegregation. Indeed, phosphorylation of Rb deregulates 
transcription factor E2F, and well-characterized targets of E2F include multiple genes 
whose products are required to maintain cell division [37-39]. The integrity of 
chromosomal DNA is under constant surveillance throughout the cell division. 
Surprisingly, the fact that a deregulated functional Chk2 itself might cause per se CIN 
through abnormal spindle localization is intriguing, as the role of Chk2 in the 
maintenance of genetic stability has mainly been ascribed to its function in DNA 
damage checkpoint signalling. 
When DNA damage occurs, Chk2 is first activated in the nucleus during interphase, 
spreads to the cytoplasm and localizes to the various mitotic structures because of the 
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phosphopeptide-binding ability of the FHA domain [40]. During DNA damage, 
chromosomes accumulate a number of phosphoproteins around DNA damage sites 
[41]. Chk2 may bind to specific phosphoproteins through the FHA domain forming 
numerous chromosomal foci and trap Chk2 to the structures. When this FHA domain is 
deleted, the molecule is excluded from the mitotic chromosomes and therefore does not 
mislocalize to kinetochores, spindle poles and midbody as was demonstrated in Figure 
7. Moreover, Chk2 localization to the kinetochores and midbody region suggests that 
Chk2 may directly affect spindle assembly function, similar to Aurora B kinase [42], but 
only when DNA damage exists. The data obtained in this study fit a model whereby 
abnormal expression of Chk2 and Aurora B kinase disrupts the sensitive balance of 
mitotic proteins, which in turn undermines faithful chromosome segregation [34]. If the 
relative expression levels of the proteins involved in the quality control of the machinery 
which ensures chromosome segregation fidelity is disrupted by mitotic errors and DNA 
damage, the resulting imbalance could further compromise chromosome segregation 
accuracy. 
Since Chk2 overexpression can induce oligomerization and cis- and trans 
phosphorylation of regulatory residues [43, 44], one possibility is that local enrichment 
of Chk2 at kinetochores and midbody regions facilitates Chk2 oligomerization and 
activation. This mechanism may alter regulation of Chk2-dependent processes such as 
centrosome function, cell cycle progression, and chromosome segregation. The 
discovery of a role for Chk2 in HCC, its association with DNA damage and CIN may 
have potential diagnostic and prognostic significance. Importantly, grading 
heterogeneity inside a tumour is frequently observed and may significantly limit 
diagnosis and choice of treatment. This study suggests that stratification of HCC 
patients according to CIN status and/or DNA damage may be useful to minimize the 
confounding effects of tumor CIN status in clinical trials. Along these lines, we propose 
that the diagnostic and prognostic value of Chk2 should be further verified in 
prospective clinical trials. 
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Figure legends 
 
Figure 1. Immunohistochemical detection of Chk2 and phospho-Histone 
H2A.X(Ser139) in diethylnitrosamine-induced HCC. A) Representative image of 
livers f female Wistar rats used as control (left panel) and rats HCC (right panel) which 
were given diethylnitrosamine 50 mg/L ad libitum in their drinking water for a period of 
10 weeks. Scale bar, 10mm. B) Liver sections (HCC 14 weeks) were analyzed for Chk2 
and phospho-Histone H2A.X(Ser139) expression (see nuclear staining in the right 
panels, Scale bar 200µm.). C) and D) Five animals for each time point were sacrificed 
on week 4, 6, 8, 10, 14. Chk2 and phospho-Histone H2A.X(Ser139) expression were 
determined according to H-score method. The average positive percentage was 
calculated, and a H-score between 0 and 300 was obtained where 300 was equal to 
100% of tumour cells stained brown strongly. The positive cut off was considered ≥100. 
The levels of Chk2 and phospho-Histone H2A.X(Ser139) expression are indicated as 
fold increase of cut-off values.* P<0.001 vs 8 weeks. Chk2 expression was evaluated in 
the nucleus of the HCC tissue  as indicated by the brown staining. 
 
Figure 2a. Detection of Chk2 protein in human HCC by immunohistochemistry. 
Paraffin-embedded tissue sections were stained with a specific antibody for Chk2 and 
hematoxylin and eosin. A) Normal liver with a moderate, diffuse cytoplasmic Chk2 
staining. B) Chk2 immunoreactivity in cancer tissue from a tumour classified Grade 1  
characterized by a weak focal cytoplasmic Chk2 staining. C) and D) Chk2 
immunoreactivity in cancer tissue from a tumour classified Grade 2 with a strong Chk2 
perinuclear and  moderate nuclear accumulation.  E) Chk2 immunoreactivity in cancer 
tissue from a tumour classified Grade 3 with a clear and strong nuclear staining, without 
cytoplasmic and perinuclear Chk2  staining. Scale bar 100µm. 
 
Figure 2b. CHK2 Expression in HCC subtypes from TCGA database. 
CHK2 expression from RNA-seq data was retrieved for 101 patients with TP53 
mutations and  85 patients with CTNNB1/beta-catenin mutations, using the LIHC cohort 
of 377 cases (accessed on November 16, 2016). Patients with both TP53 and CTNNB1 
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mutations were excluded from the analysis. Expression levels are expressed as log2exp 
(absolute levels) or z-score (expression levels in HCC samples normalized to the 
expression levels in the reference population).Graph shows mean ± SEM, *p<0.0001 
 
 
Figure 3. Defective chromosome segregation  causes Chk2 overexpression in 
hTERT immortalized human hepatocytes. A) Examples of chromosome numbers 
from metaphase spreads of HCT116, Huh7 and HuS0gen cells (upper panels). In the 
bottom panels individual chromosome numbers percentage from metaphase spreads of 
HCT116, Huh7 and HuS0gen cells are represented (n=20). B) Representative 
immunoblot out of three independent experiments demonstrating the protein levels of 
Chk2 in indefinite cultured HCT116 and Huh7 cells, in HuS0gen cells and HuS0gen 
cells after 30 generations in culture (HuS30gen). C) Example of chromosomes from 
metaphase spreads of HuS30gen exhibiting numerical and structural (red arrow) 
alterations; the histogram shows individual chromosome numbers percentage in 
HuS30gen (n=20). D) Representative immunoblot out of three independent experiments 
demonstrating the protein levels of phospho-Histone H2A.X (Ser139), a hallmark of 
DNA damage,  in indefinite cultured   HCT116, Huh7,  HuS0gen  and HuS30gen cells. 
 
Figure 4. Chk2 overexpression is linked to lagging chromosomes. A) Chk2 co-
localizes with chromosomal structures only in HuS30gen cells. Asynchronously growing  
HCT116, Huh7, HuS0gen and HuS30gen cells  were synchronized in metaphase by 
releasing cells  from  thymidine treatment into MG132. Metaphase mitotic  spindles  
were monitored by immunofluorescence and typical examples are given,   endogenous 
Chk2 (red); kinetochores, CENP-H (green); chromosomes  are stained with Hoechst 
33342 (blue).   Chk2 co-localization with chromosome structures was quantified in 
metaphases (mean±SD; n≥ 300 metaphases)  B) HuS0gen that express low levels of 
protein Chk2  were stably transfected with HA-tagged Chk2 and asynchronously 
growing cells were evaluated for lagging chromosomes; typical examples of lagging 
chromosomes containing anaphase and telophase are given (HA-Chk2, red; CENP-H, 
green; chromosomes, Hoechst 33342, blue). C) Asynchronously growing HuS30gen 
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cells expressing H2B-GFP (to visualize in vivo  lagging chromosomes) were analyzed 
by live cell microscopy. Left, phase-contrast images; middle, fluorescence images; right, 
merge. Scale bar, 10 µm. D) Asynchronously growing cells, HCT116, Huh7, HuS0gen,  
HuS30gen, and  HuS0gen stably transfected with HA-tagged Chk2 (HuS-Chk2) were 
stained with CENP-H (constitutive component of kinetochores) and Hoechst 33342 
(chromosomes). Anaphase and telophase lagging chromosomes were counted by 
immunofluorescence, (mean ± SD; n= 500 cells) *p<0.01 vs HuS0gen. **p<0.05 vs 
HuS-mock 
 
Figure 5. Overexpressed/phosphorylated Chk2 is correlated with increased 
chromosomal missegregation. A) HuS30gen cells were stably retrovirally-transduced 
either with a control shRNA (shCTL) or shRNAs  targeting CHK2 (shChk2). Chk2-
depleted HuS30gen cells were used to reconstitute expression of CHK2 by introducing 
a shRNA resistant mutant of CHK2 (myc-Chk2resist). The protein levels were 
determined by immunoblotting and a representative example is shown. B) 
Asynchronously growing cells HuS30-shCTL, HuS30-shChk2 and Chk2-depleted 
HuS30gen reconstituted with shRNA resistant mutant of CHK2 were stained with 
CENP-H (kinetochores) and Hoechst 33342 (chromosomes). Anaphase and telophase 
lagging chromosomes counted by immunofluorescence, (mean ± SD; n= 500 cells), *p < 
0.01vs controls. C) The mitotic index of asynchronously growing cells HuS30-shCTL, 
HuS30- shChk2 and Chk2-depleted HuS30 reconstituted with shRNA resistant mutant 
of CHK2 was measured by counting the mitotic figures (prophase, metaphase, 
anaphase, and telophase) positively stained for phosphorylated histone H3 (pHH3).The 
mitotic index was calculated as percentage of mitotic cells/total cells as described in 
Materials and Methods. Error bars show the SD from the means of three independent 
experiments, *p<0.01vs controls. D)  Chk2 phosphorylation levels on Thr68 and Thr387. 
Representative immunoblot out of three showing asynchronously growing HCT116, 
HuS0gen, HuS30gen, and HuS0gen stably  transfected with Chk2 (HuS-Chk2). Cell  
lysates  were immunoblotted against p-Thr68-Chk2 and p-Thr387-Chk2. E) Activated 
Chk2 localizes with mitotic structures in HuS30gen cells. Example of metaphase, 
anaphase and telophase from unstable HuS30gen cells  and stable HCC cell line, 
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Huh7. Activated Chk2 (p-Thr68-Chk2, red) co-localizes with CENP-H, constitutive 
component of kinetochores (green) only in HuS30gen. Arrowheads indicate lagging 
chromosomes,  (Hoechst 33342, blue). Scale bar, 10 µm.   
 
Figure 6. Up-regulated Chk2 cooperates with  Aurora B for chromosome 
condensation and cytokinesis 
A)HuS0gen cells showing expression and localization of endogenous Chk2 (red),   
Aurora B kinase (green), and chromosomes (Hoechst 33342, blue) B) Co-localization of 
Aurora B kinase (green) with HuS0gen  overexpressing  HA-tagged Chk2 (red) in  
mitoses with lagging chromosomes (Hoechst 33342, blue). Cells were fixed and 
analyzed by fluorescence microscopy. Arrows indicate spindle midzone region, 
arrowheads indicate midbody region. C) HuS0gen cells overexpressing HA-tagged 
Chk2 were stained with antibody anti-HA (red) and phospho-Histone H3 (green) to show 
co-localization of Chk2 with missegregating chromosomes. Scale bar, 10 µm. 
 
 
Figure 7.  FHA domain is essential for Chk2 localization and contributes to 
sustain   lagging chromosomes. Red fluorescent protein was conjugated at the N-
terminus of each Chk2 mutant. Left, schematic diagrams. RFP was omitted. RFP-Chk2 
mutants were transfected in HuS30gen cells, synchronized and blocked in metaphase 
by treatment with MG132 for 2 hours, the cells were analyzed by fluorescence 
microscopy. A) Expression and subcellular localization of RFP-Chk2. RFP-Chk2 
decorates the spindle poles (two red dots), and localizes with kinetochores (CENP-H, 
green), chromosomes are stained with Hoechst 33342, blue. B) RFP-Chk2D347A, 
kinase dead mutant (KD), localizes similarly to RFP-Chk2. C) RFP-Chk2∆FHA does not 
localize to mitotic structures. D) RFP-FHA localizes to spindle poles, kinetochores. FHA 
domain tagged with RFP is similar to RFP-Chk2. Scale bar, 10 µm. E) Quantification of 
lagging chromosomes during anaphases and telophases  in HuS0gen  cells stably  
expressing Chk2(KD), Chk2∆FHA and Chk2FHA mutants.  Chk2 FHA mutant   
significantly reduces  the number of lagging chromosomes as a result of   the  dominant 
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negative effect    towards  endogenous Chk2. mean±SD; n=400 anaphases and 
telophases. *p<0.01vs control 
 
Figure 8. P53 and phosphorylated Rb expression in HCT116, HuS30gen and 
HuS0gen. A) Representative immunoblot out of three showing the protein levels of p53 
in HCT116, Huh7, HuS30gen and HuS0gen cells. In the same blot are represented p53 
expression levels of HuS0gen cells after treatment with DNA-damaging agent 5-
fluorouracil (5-FU, 1µM). B) Representative images of HCT116, Huh7 and HuS30gen 
cells fixed and stained with an antibody directed against the mutated codon TGT at  
position 220   of  p53 protein. Huh7 cells,   previously characterized  as p53 mutated 
(see reference 30),   are used as positive control. C) Representative immunoblot out of 
three independent experiments showing the protein levels of Rb and phosphorylated 
Rb, p-Rb (Ser807/811), in HCT116, HuS30gen and HuS0gen cells. D), E) and F) 
Mitoses of asynchronously growing HCT116, HuS30gen and HuS0gen cells stained 
with the  antibody specific for phosphorylated Rb and analyzed by fluorescence 
microscopy; p-Rb (Ser807/811) red; chromosomes (Hoescht 33342,  blue). Scale bar, 
10 µm.  
 
Figure 9. A proposed schema  illustrating the mechanism by which Chk2 
overexpression  and mislocalization sustains  defective mitoses throughout hepatic 
tumorigenesis. Mitotic errors  represented by lagging chromosomes cause DNA 
damage and  overexpress   Chk2  in  genetically unstable cells. Chk2  and 
phosphorylated forms of Chk2 mislocalize within the mitotic structures in the presence 
of DNA damage contributing to increase the  numbers of  lagging chromosomes.  
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Significance of this study 
What is already known on this subject? 
• Chromosomal instability (CIN), is a major hallmark of hepatic tumorigenesis and 
hampers prognosis and therapy. The underlying mechanisms are not well 
characterized. 
• CIN is regarded as an ongoing elevated frequency of mitotic errors that leads to 
numerical and structural chromosome aberrations in a significant proportion of 
cell divisions leading to intra-tumoral heterogeneity and drug resistance. 
• DNA damag  caused by genotoxic agents activates DNA damage response 
checkpoint kinase 2 (Chk2)  protein expression 
• Mislocalization of proteins, including oncoproteins, tumor suppressors, and other 
cancer-related proteins, can interfere with normal cellular function and 
cooperatively drive tumor development 
 
What are the new findings? 
• Mitotic errors  represented by lagging chromosomes cause DNA damage and  
overexpress   Chk2  throughout hepatic tumorigenesis  
•  Chk2  and the activation/phosphorylated forms of Chk2 mislocalize within the 
mitotic structures in the presence of DNA damage contributing to increased 
numbers of cells with lagging chromosomes. In contrast, knockdown of Chk2 
reduces  the number of cells with lagging chromosomes  and the mitotic index  
• The Chk2 forkhead-associated domain (FHA) is responsible for the 
mislocalization of the protein at the mitotic structures  
• Chk2 is expressed at the nuclear level in a subset of human HCC  and this 
aspect correlates with HCC progression. Moreover, CHK2 expression is 
significantly higher in HCC patients with mutated TP53, a hallmark of genomic 
instability, than in those with mutated CTNNB1/beta-catenin. 
How might it impact on clinical practice in the foreseeable future? 
• The study reveals a new mechanistic insight in the co-involvement of Chk2 in 
CIN i.e. Chk2 mislocalization, hence indicating the possibility to use Chk2 as a 
new drug target in HCC 
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• The findings of this study suggest Chk2 as a putative biomarker that can be used 
to detect DNA damage and  chromosomal instability in HCC providing a valuable 
support, not only for prognosis, but also for identifying patients who are likely to 
have a response to therapy.  
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ABSTRACT 
Objective 
Chromosomal instability (CIN) is the most common form of genomic instability, that 
promotes hepatocellular carcinoma (HCC) progression by enhancing tumour 
heterogeneity, drug resistance and immunity escape. CIN per se is an important factor 
of DNA damage, sustaining structural chromosome abnormalities   but the underlying 
mechanisms are unknown. 
Design 
DNA-damage response protein  Chk2  expression was evaluated in an animal model of 
diethylnitrosamine-induced HCC characterized by DNA damage and elevated mitotic 
errors. Chk2  was also determined in two  discrete cohorts of human HCC specimens. 
To assess the functional role of Chk2, gain on- and loss-of-function, mutagenesis, 
karyotyping, and immunofluorescence/live imaging were performed by using HCT116, 
Huh7 and human hepatocytes immortalized with hTERT gene (HuS). 
Results 
We demonstrate that mitotic errors during HCC tumorigenesis cause lagging 
chromosomes/DNA damage and activation of Chk2. Overexpression/phosphorylation 
and   mislocalization within the mitotic spindle  of  Chk2   contributes to induce  lagging  
chromosomes. Lagging chromosomes and mitotic activity are reversed by knockdown 
of Chk2. Furthermore,  up-regulated Chk2 maintains  mitotic activity interacting with 
Aurora B kinase for chromosome condensation and cytokinesis. The forkhead-
associated (FHA) domain of Chk2 is required for Chk2  mislocalization to mitotic 
structures. In addition, retinoblastoma  protein phosphorylation contributes to defective 
mitoses. A cohort  and independent validation cohort show a strong cytoplasm-to 
nuclear Chk2  translocation in a subset of  HCC patients. 
Conclusions 
The study reveals a new mechanistic insight in the co-involvement of Chk2 in HCC 
progression. These findings propose Chk2 as a putative biomarker to detect CIN in 
HCC providing a valuable support for clinical/therapeutical management of patients. 
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Introduction 
Hepatocellular carcinoma (HCC) is the primary malignancy of hepatocytes and the most 
frequent solid tumour of the liver. Half a million cases occur annually and the World 
Health Organization has recently ranked HCC as the second most lethal cancer 
worldwide [1]. Different etiological factors such as hepatitis B and C virus, alcohol and 
diabetes cause liver injury followed by inflammation, necrosis and hepatocytes 
proliferation [2]. Continuous cycles of this destructive–regenerative process culminates 
in liver cirrhosis which is characterized by regenerating nodules that progress to 
dysplastic nodules and ultimately HCC [3,4]. More than 90% of HCC, including 
dysplastic nodules in cirrhotic liver, possess chromosomal aberrations suggesting that 
chromosomal defects occur at early stages of tumour development and several 
attempts have been made to connect different chromosomal aberration patterns as 
specific subsets of HCC, albeit with limited success [5-7]. A common feature of human 
HCC and dysplastic nodules is represented by chromosomal instability (CIN). Various 
types of chromosomal aberrations, including numerical (aneuploidy) and structural (e.g., 
translocations, deletions), are found in HCC and are linked to tumorigenesis [8,9]. An 
important aspect in studying HCC tumorigenesis is to distinguish between the state of 
the karyotype, and the rate of karyotypic change. In fact, aneuploidy is not synonymous 
with CIN, because  aneuploid tumours are stable  with uniform karyotype and 
phenotype [10-12]. Conversely,  there is an  increased rate of CIN generating  diverse 
karyotypes within the same  tumour. This  yields a heterogeneous tumour cell 
population that has the ability to undergo selective evolution in term of drug resistance 
and  immune system escape mechanisms [13-15]. CIN is regarded as an ongoing 
elevated frequency of mitotic errors that leads to additional chromosome gains or losses 
in a significant proportion of cell divisions. Our hypothesis is that CIN per se is also an 
important mechanism of DNA damage inducing  structural chromosome aberrations in 
HCC. To verify this hypothesis we utilized   checkpoint kinase 2 (Chk2) as a central 
effector of the cell response to DNA damage. In fact,  Chk2 has been described   to 
detect a variety of DNA lesions  caused by exogenous and endogenous genotoxic 
agents. Our aim is   to investigate the expression of this kinase in hepatic 
carcinogenesis and its correlation with the genesis of structural chromosomal 
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aberrations. Here, we provide evidence that  defective chromosome segregation i.e.  
lagging chromosomes causes DNA damage and determines an 
overexpression/phosphorylation  of Chk2. Furthermore,  the  mislocalization of Chk2 
with components of the mitotic spindle  contributes to chromosome missegregations  
and DNA damage. These data are  corroborated with the observation of an increased 
Chk2 and nuclear translocation in two independent cohorts of human HCC specimens.  
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Materials and Methods 
Please refer to the Supplementary Materials and Methods  for more detailed 
descriptions. 
 
Tissue Samples and Immunohistochemistry Assays. 
Florence cohort, University Hospital of Florence; formalin-fixed, paraffin-embedded 
tissue were obtained from an archive of liver biopsies of patients diagnosed with  HCC.  
H&E-stained tissue sections of 49 patients  were reviewed, and areas of cirrhotic and 
HCC were identified.  Chk2 antigen retrieval was performed by heating in citrate buffer 
pH 6.0 at 98°C for 30 minutes. Non-specific signal was eliminated by peroxidase block 
for 10 minutes at RT. Primary antibody was incubated at room temperature overnight in 
a humidified chamber followed by HRP-conjugated secondary antibody incubation for 
30 minutes at room temperature. Antibody binding was revealed by DAB and reaction 
was stopped by immersion of tissue sections in distilled water once brown colour 
appeared. Tissue sections were counterstained by hematoxylin, dehydrated in graded 
ethanols and mounted. All reagents for immunohistochemistry were from Dako. 
Appropriate positive and negative controls were included for each run of 
immunohistochemistry. Chk2 expression was determined according to H-score method. 
For H-score assessment, 10 fields were chosen at random at x400 magnification and 
the staining intensity in the malignant cell nuclei was scored as 0, 1, 2, and 3 
corresponding to the presence of negative, weak, intermediate, and strong brown 
staining, respectively. The total number of cells in each field and the number of cells 
stained at each intensity were counted. The average percentage positive was 
calculated, and a H-score between 0 and 300 was obtained where 300 was equal to 
100% of tumor cells stained brown strongly. The positive cut off was considered ≥100 
(supplemental Figure S1). Chk2 expression in biopsy sections was scored by a 
pathologist and two researchers independently. 
London cohort, Royal Free Hospital; formalin-fixed, paraffin-embedded surgical 
specimens from consecutive  patients diagnosed with  HCC were retrieved from Royal 
Free Hospital archives. All samples were stained with H&E and the sections were 
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reviewed and suitable areas of cirrhosis and HCC were identified in 20 samples. 
Antigen retrieval was performed by microwaving (720W) in pH 6.0 sodium citrate buffer 
for 30 mins. Endogenous peroxidase and non-specific binding of primary antibody was 
blocked. The primary Chk2 antibody was incubated at overnight at 5°C. Primary  
antibody detection was carried out using the Novolink polymer detection system 
(Novocastra).Tissue sections were counterstained with Mayer’s hematoxylin. 
 
Experimental hepatocarcinogenesis.Twenty-five female Wistar rats (210-225 g) were 
given diethylnitrosamine 50 mg/L ad libitum in their drinking water for a period of 10 
weeks as previously described [16]. Another group of five animals were maintained as 
controls. All animals were administered a standard laboratory diet and were weighed 
each week. Five animals for each time point were sacrificed on week 4, 6, 8, 10 and, 
14.Tumours and liver tissues were removed and fixed in 10% neutral buffered formalin. 
Liver sections (5µm)   were cut from paraffin-embedded blocks and stained Chk2 
(Abcam, #ab47433), phospho-Histone H2A.X (Cell Signaling, #9718)  and hematoxylin 
and eosin (H&E) for histological examination and expression were determined 
according to H-score method. 
 
CHK2 Expression in HCC samples from Cancer Genome Atlas (TCGA) database. 
The TCGA-LIHC cohort, containing 377 cases, was used to validate CHK2 expression 
levels in distinct subtypes of HCC. The TCGA database (https://gdc-portal.nci.nih.gov) 
was accessed on November 16, 2016 through the cGbioportal website 
(http://www.cbioportal.org/) to retrieve patients with either TP53 or CTNNB1 mutation. 
The TCGA_participant_barcode was used to download CHK2 expression from RNA-seq 
data using the firebrowse portal (http://firebrowse.org). Patients with co-occurrent 
mutations of TP53 and CTNNB1 were excluded from the analysis. CHK2 expression 
levels were retrieved for 101 patients with TP53 mutation and 85 patients with CTNNB1 
mutation. Statistical analysis was performed  using the Mann-Whitney test with 
GraphPad 6 software. 
 
 
Page 35 of 79
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
9 
 
 
Results  
 
Chk2 is overexpressed in a subset of human HCC 
To test our hypothesis that hepatic tumorigenesis per se could be a cause of DNA 
damage and structural chromosome aberrations, an animal model of diethylnitrosamine-
induced HCC was employed which induced macroscopical visible tumours after 14 
weeks (Figure 1A).This model has previously been established to induce elevated 
mitotic errors, DNA damage and chromosome aberrations [17]. Using this model we can 
compare the expression levels of DNA damage response proteins induced by the 
genotoxic activity of diethylnitrosamine with a later phase represented exclusively by 
tumorigenesis. Therefore, Chk2, a DNA damage-response checkpoint kinase,  and 
phospho-Histone H2A.X (Ser139) a component of chromatin which becomes 
phosphorylated following DNA damage (e.g. DNA double-stranded breaks)  were 
investigated [18].   As shown in Figure 1B several nuclei of cancer cells exhibited an 
increased expression of Chk2  and phospho-Histone H2A.X  revealing the presence of 
DNA damage.  A timeline analysis of liver sections demonstrated  a two-fold increase in 
Chk2 basal levels at 4 weeks followed by decreased values after 8 weeks (Figure 1C). 
In contrast, by 14 weeks tumours were macroscopically visible and histologically evident 
in 80% of animals. Immunostaining of HCC sections showed a significant increased 
expression of Chk2 and phospho-Histone H2A.X (Figure 1C and 1D) when compared 
with liver sections without evidence of tumours (8 weeks). Taken together, these data 
showed that the increased expression of Chk2 reflected a response triggered by DNA 
damage during tumorigenesis. 
To extend these findings to humans, the expression of Chk2 in patients with cirrhotic-
related HCC and normal liver was examined in liver biopsies from hospital archives 
(Florence cohort, supplemental Table 1). A nuclear staining of Chk2 was detectable in 
distinctive histotypes of HCC (supplemental   Figure S2 and  S3). More specifically, the 
expression level of Chk2 in different grades of HCC was evaluated. Remarkably, within 
histological grade II and III, significant quantitative differences between positive and 
negative Chk2 patients were found (p<0.001). Overall, these data demonstrated that 
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Chk2 nuclear positivity was found in 63.2% (31 of 49) of HCCs analyzed (supplemental  
Table 2 ). A separate validation cohort of patients was examined at Royal Free Hospital, 
London (supplemental Table 3). Normal liver tissue showed a moderate and diffuse 
cytoplasmic staining, whereas Grade 1 specimens were characterized with weak focal 
cytoplasmic Chk2 staining. In Grade 2, a Chk2 perinuclear and nuclear accumulation 
was observed.  Specimens with Grade 3 showed exclusively a clear and strong nuclear 
staining, without cytoplasmic and perinuclear Chk2 staining (Figure 2a and 
supplemental Table 4). Furthermore, the expression levels of CHK2 were analyzed in a 
public available cohort of HCC from the TCGA database. We found a highly-significant 
increase of CHK2 expression in HCC with mutated TP53, a hallmark of genomic 
instability, with respect to those with CTNNB1/beta-catenin mutation (Figure 2b).  
 
 
Defective chromosome segregations cause DNA damage  
The previous observations prompted us to investigate the functional role of Chk2.  For 
this reason, three different cell lines were employed. The colon carcinoma cell line 
HCT116 was used i.e. a near-diploid cell line that faithfully segregates chromosomes to 
maintain a stable karyotype and is commonly employed in CIN studies [19,20]. 
Secondly, the HCC cell line Huh7 was used which is a stable hyperdiploid karyotype 
with altered chromosomal structures and finally HuS cells were used marked with an 
unstable karyotype [21]. HuS cells are human hepatocytes immortalized with human 
telomerase reverse transcriptase (hTERT), a gene described commonly activated in 
human HCC [8, 9]. HuS cells just established in culture (0 generation) and hereafter 
referred to as HuS0gen showed a karyotype with a distribution of 46 chromosomes 
(Figure 3A) and expressed low levels of Chk2 protein in comparison to HCT116 and 
Huh7 (Figure 3B). The HuS0gen cells were maintained in culture and after 30 
consecutive generations (HuS30gen) were re-examined to verify the karyotype status. 
The cells showed a distribution near-triploid, with many structural chromosomal defects 
(Figure 3C and supplemental Figure S4A)  and importantly  this aspect was associated 
with increased expression of Chk2 protein, (Figure 3B). Likewise  with the murine  
model, we evaluated the expression levels of phospho-Histone H2A.X (Ser139) in all 
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the cell lines studied. As shown in Figure 3D, both HuS0gen and HuS30gen cells 
exhibited high levels of phospho-Histone H2A.X, although with different levels of 
expression. These findings indicate the presence of DNA double-strand breaks, a 
hallmark of DNA damage, in HuS cells.  
  
Overexpressed Chk2 mislocalizes with mitotic structures in HuS30gen cells but 
not in HCT116 and Huh7.  
The finding of overexpressed Chk2 in both karyotyped stable HCT116 and Huh7 and  in 
unstable karyotyped HuS30gen did not demonstrate a specific role for Chk2 in defective 
chromosome segregation. Therefore, we analyzed the cell lines HCT116, Huh7, 
HuS0gen and HuS30gen by immunofluorescence to examine a possible altered 
localization of Chk2 with the mitotic structures. Chk2  showed a  localization to the 
spindle poles of metaphase mitotic structures in HCT116, Huh7, and HuS0gen (Figure 
4A).   Very importantly, HuS30gen cells showed a robust localization of Chk2  with all  
metaphase mitotic structures indicating a clear mislocalization of Chk2  (Figure 4A and 
supplemental Figure S4B). These results suggest that in  HuS0gen cells, expressing 
low levels of DNA damage,  Chk2 weakly co-localized with the mitotic spindle 
components, whereas  Chk2 is increased and strongly associated with all mitotic 
structures in HuS30gen cells  that are expressing high levels of DNA damage. To 
further address these findings  we stably transfected HuS0gen with HA-tagged Chk2,   
HuS0gen overexpressing Chk2  exhibited    Chk2  localization  with mitotic structures as 
shown in Figure 4B. Next, we measured the number of  lagging chromosomes (Figure 
4C) in HuS0gen, HuS30gen, and in HuS0gen stably transfected with HA-tagged Chk2 
to mimic overexpression of Chk2. As shown in Figure 4D, overexpression of Chk2 
significantly correlated with high number of mitoses with lagging chromosomes in 
HuS30gen, and in HuS0gen overexpressing HA-tagged Chk2. These data clearly 
indicate that indeed overexpression and mislocalization  of Chk2 itself contributes to 
defective chromosome segregations. Furthermore,  to assess that the increased 
expression of Chk2 was  specifically  related to those  mitoses with defective 
chromosome segregations   and not  a random  deregulation of proteins, the expression 
of Nek2 (NIMA related kinase 2)  protein was evaluated. Nek2 is a protein located at the 
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centrosome/spindle poles and responsible for chromosomal defective segregations [22]. 
HCT116 and Huh7 cells showed a strong Nek2 expression whereas both HuS0gen and 
HuS30gen cells expressed low levels of Nek2 (supplemental Figure S5) suggesting that 
the previously observed  overexpression of Chk2 in Hus30gen was a specific event that 
coincided with structural chromosomal defects and DNA damage.  
 
 
Chk2 overexpression is correlated with increased  chromosomal missegregations  
The    findings  that  HuS30gen express high levels of Chk2 protein   correlating  with 
DNA damage (Figure 3B and 3D), prompted us to  investigate the effects of knocking 
down expression of CHK2 in HuS30gen cells by retroviral-mediated short hairpin RNA 
(shRNA) transduction. A pool of four shRNA targeting Chk2 resulted in effective 
decrease of the protein (Figure 5A). It is important to note that silencing CHK2 coincided 
with a significant reduction of  the number of HuS30gen cells with lagging chromosomes  
and HuS30gen mitotic index.  To address any off target effects of the hairpins, we 
rescued the mitotic index and the number of cell with lagging chromosomes of the 
knockdown HuS30gen by expressing a myc-tagged version of Chk2 that circumvents 
the shRNA directed against human Chk2 (Figure 5B and 5C). These data demonstrate 
that Chk2 overexpression is correlated with increased  chromosomal missegregation 
and mitotic index. 
 
 
Defective mitoses-related DNA damage promotes Chk2 phosphorylation and 
mislocalization within mitotic structures. 
Human CHK2, is a 543 amino acid protein that consists of a N-terminal SQ/TQ cluster 
domain (SCD), a central forkhead-associated (FHA) domain, and a C-terminal 
serine/threonine kinase domain [23]. The SCD consists of multiple SQ/TQ (Ser-Gln/Thr-
Gln) motifs with Thr68 being the primary site to be phosphorylated in response to DNA 
damage followed by phosphorylation of Thr387 in the activation loop of the kinase 
domain [24, 25]. Therefore, the  protein expression of phospho-Thr68-Chk2 and 
phospho-Thr387-Chk2 in HuS30gen and HuS0gen stably transfected with HA-tagged 
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Chk2 were assessed. As shown in Figure 5D phospho-Thr68-Chk2 and phospho-
Thr387-Chk2 were highly expressed in HuS30gen and in HuS0gen stably transfected 
with HA-Chk2, but not in HuS0gen as expected. Furthermore, phospho-Thr68-Chk2 
revealed a robust localization with components of the mitotic spindle as previously  
shown for Chk2. In particular, a prominent association of phospho-Thr68-Chk2 was 
observed with mitotic structures such as the spindle poles, kinetochores and midbody in 
Hus30gen cells, (Figure 5E, upper panels). In contrast, Huh7 cells  expressing   low 
levels of DNA damage ( see Figure 3D)  did not  show co-localization of phospho-
Thr68-Chk2 with mitotic structures, (Figure 5E, lower panels). Taken together, these 
results reveal an overexpression/mislocalization of phosphorylated Chk2,  which is 
correlated with its activation status, and manifestations of lagging chromosomes-
induced DNA damage. 
 
 
Up-regulated Chk2 cooperates with Aurora B for chromosome condensation and 
cytokinesis. 
As previously shown the typical localization of activated Chk2 in HuS30gen cells was 
observed in kinetochores and specifically the midbody, suggesting a possible interaction 
with Aurora B kinase. This protein is known to be involved in chromosome 
condensation, the assembly of the spindle midzone in anaphase and the midbody 
during telophase. Furthermore, Aurora B kinase has been identified as an effective 
predictor of aggressive HCC recurrence, in relation to genomic instability [26]. 
Therefore, HuS0gen cells were transfected with HA-tagged Chk2 and 
immunofluorescence analyses revealed a co-localization of Chk2 with Aurora B 
throughout all mitotic phases, and this co-localization was also present in cells marked 
with lagging chromosomes (Figure 6A and 6B). Aurora B is responsible for the 
phosphorylation of histone H3 (pHH3),  and pHH3 serine residue (Ser-10) is considered 
to be a crucial event for the onset of mitosis. The utility of pHH3 to identify mitoses has 
been demonstrated in several cancer studies [27-29]. As, the co-localization of Aurora B 
with Chk2 was demonstrated we further explored the co-localization of overexpressed 
HA-Chk2 with pHH3. As shown in Figure 6C, Chk2 exhibited a striking co-localization 
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with pHH3. Overall, the data so far demonstrate that in  unstable HuS cells during 
mitosis, lagging chromosomes cause DNA damage,  overexpression  of Chk2 which 
localizes to all mitotic structures. This overexpressed and mislocalized Chk2 protein 
contributes to a constant mitotic activity and more important Aurora B kinase and pHH3 
interact with Chk2. This favours a possible scenario where an overexpressed and 
mislocated Chk2 overrules the signalling specificity at distinct mitotic checkpoints 
inducing itself chromosomal aberrations, hence CIN. 
 
The forkhead associated domain (FHA) determines Chk2 mislocalization to 
mitotic structures and is essential for DNA damage response 
To understand how Chk2 is recruited to the mitotic structures in such a specific manner, 
we investigated Chk2 specific domain(s) that are  required for Chk2 localization.  A 
series of RFP-tagged Chk2 variants were created, each  variant carrying a point 
mutation or a deletion, and were expressed and localized individually in HuS30gen. The 
RFP-Chk2D347A, a kinase-inactive mutant, localized similarly as shown for RFP-Chk2 
(Figure 7A). This indicated  that the kinase activity is dispensable for Chk2 
mislocalization (Figure 7B). The FHA domain of Chk2 has been proposed to mediate 
localization of Chk2 to mitotic structures for the reason that FHA domains function as 
phospho-threonine-binding protein motifs. The deletion of the Chk2 FHA domain 
disrupted the localization of the protein to mitotic structures such as the spindle poles 
and kinetochores indicating that the deletion of the FHA is responsible for the observed 
mislocalization (Figure 7C). Indeed, the entire FHA domain RFP-tagged localized to 
mitotic structures similar to RFP-Chk2 (Figure 7D). Along these lines, we can conclude 
that the FHA domain is required for proper Chk2 localization to mitotic structures. 
Furthermore, we analyzed the effects of the several Chk2 mutants on lagging 
chromosomes. Interestingly, transfection of HuS0gen with Chk2 FHA domain   
significantly reduced  the number of lagging chromosomes (Figure 7E). This result 
suggests  a dominant negative effect of  Chk2 FHA domain   towards  endogenous 
Chk2. 
 
Rb phosphorylation contributes to defective mitoses in HuS cells. 
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An important point raised by defective mitoses-related DNA damage as observed in this 
study is why the cells do not sense signals deployed to curb cell proliferation, as 
normally the growth of cultured diploid cells is halted by chromosome missegregation. In 
HCC, p53 deficiency has been described to participate in the development of CIN, 
however the relevance of p53 to HCC initiation, progression, or both, remains an area of 
active investigation [2]. Therefore, the basal level of p53 in HCT116, Huh7, HuS30gen 
and HuS0gen was investigated. As shown in Figure 8A, p53 was expressed in Huh7 
and at  low level in HuS30gen cells. HuS0gen cells did not  express p53 in basal 
conditions, however   treatment of the cells  with   5-fluorouracil, a DNA-damaging 
agent,  triggered a strong  p53 protein expression. Based on these findings  we assume  
that  p53 expression  may   be a late event  in  HuS cells, as  a result of several  
defective mitoses [19].  Furthermore, mutated p53 was not present in HCT116 and 
HuS30gen cells in contrast to Huh7 cells that  we used as a positive control (Figure 8B) 
[30]. 
 The possible involvement of the retinoblastoma protein Rb was evaluated since several 
studies have described Rb as an important regulator of cell division [31]. Specifically, 
Rb phosphorylation determines Rb inactivation and leads to defective mitoses [31]. 
Therefore, we evaluated the protein expression levels of phospho-Rb (Ser807/811) in  
HCT116, HuS0gen cells and  HuS30gen. As shown in Figure 8C  HuS30gen cells 
express higher levels of phospho-Rb (Ser807/811) in comparison to HuS0gen cells. 
Moreover, HCT116 (Figure 8D), HuS30gen (Figure 8E) and HuS0gen (Figure 8F) 
exhibited a localization of phospho-Rb (Ser807/811) at the chromosomal level. Taken 
together, these findings suggest that in HuS30gen Rb phosphorylation is required to 
sustain mitotic activity which leads to mitotic defects.  
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Discussion 
The neoplastic evolution of HCC proceeds through a multi-step histological process that 
is less well defined than that of other cancer types. Hyperplastic nodules of regenerating 
hepatocytes have normal karyotype and represent a potential first step towards HCC. 
These lesions can progress to dysplastic nodules, which have abnormal chromosome 
features including numerical and structural alterations. These dysplastic nodules can 
evolve to HCC marked  with recurrent regions of copy number change and allelic 
imbalances [3, 4].  Loss of certain tumour suppressors or gain of specific oncogenes 
promote cell division as shown in many previous studies  [25, 32]. We demonstrate  that 
this coincides  with defective mitoses which can cause DNA damage. This scenario is 
conceivable considering that massive deregulation of mitosis is incompatible with cell 
survival and can even be tumour suppressive [33]. Therefore, subtle rather than 
massive mitotic defects are expected to underlie CIN in HCC, allowing a tolerable level 
of chromosome defects. To support this view we have provided  evidence in this study 
that hepatocarcinogenesis with  lagging chromosomes elicits the expression of DNA 
damage response protein Chk2. Thus,  the overexpression of Chk2 and its 
mislocalization within structures of   the mitotic spindle sustains cell division and 
chromosomes missegregation [34-36]. This forms a self-perpetuating mechanism 
causing  DNA damage (Figure 9).  
 We have also found that functional Rb inactivation is necessary but not sufficient to 
trigger chromosome missegregation. Indeed, phosphorylation of Rb deregulates 
transcription factor E2F, and well-characterized targets of E2F include multiple genes 
whose products are required to maintain cell division [37-39]. The integrity of 
chromosomal DNA is under constant surveillance throughout the cell division. 
Surprisingly, the fact that a deregulated functional Chk2 itself might cause per se CIN 
through abnormal spindle localization is intriguing, as the role of Chk2 in the 
maintenance of genetic stability has mainly been ascribed to its function in DNA 
damage checkpoint signalling. 
When DNA damage occurs, Chk2 is first activated in the nucleus during interphase, 
spreads to the cytoplasm and localizes to the various mitotic structures because of the 
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phosphopeptide-binding ability of the FHA domain [40]. During DNA damage, 
chromosomes accumulate a number of phosphoproteins around DNA damage sites 
[41]. Chk2 may bind to specific phosphoproteins through the FHA domain forming 
numerous chromosomal foci and trap Chk2 to the structures. When this FHA domain is 
deleted, the molecule is excluded from the mitotic chromosomes and therefore does not 
mislocalize to kinetochores, spindle poles and midbody as was demonstrated in Figure 
7. Moreover, Chk2 localization to the kinetochores and midbody region suggests that 
Chk2 may directly affect spindle assembly function, similar to Aurora B kinase [42], but 
only when DNA damage exists. The data obtained in this study fit a model whereby 
abnormal expression of Chk2 and Aurora B kinase disrupts the sensitive balance of 
mitotic proteins, which in turn undermines faithful chromosome segregation [34]. If the 
relative expression levels of the proteins involved in the quality control of the machinery 
which ensures chromosome segregation fidelity is disrupted by mitotic errors and DNA 
damage, the resulting imbalance could further compromise chromosome segregation 
accuracy. 
Since Chk2 overexpression can induce oligomerization and cis- and trans 
phosphorylation of regulatory residues [43, 44], one possibility is that local enrichment 
of Chk2 at kinetochores and midbody regions facilitates Chk2 oligomerization and 
activation. This mechanism may alter regulation of Chk2-dependent processes such as 
centrosome function, cell cycle progression, and chromosome segregation. The 
discovery of a role for Chk2 in HCC, its association with DNA damage and CIN may 
have potential diagnostic and prognostic significance. Importantly, grading 
heterogeneity inside a tumour is frequently observed and may significantly limit 
diagnosis and choice of treatment. This study suggests that stratification of HCC 
patients according to CIN status and/or DNA damage may be useful to minimize the 
confounding effects of tumor CIN status in clinical trials. Along these lines, we propose 
that the diagnostic and prognostic value of Chk2 should be further verified in 
prospective clinical trials. 
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Figure legends 
 
Figure 1. Immunohistochemical detection of Chk2 and phospho-Histone 
H2A.X(Ser139) in diethylnitrosamine-induced HCC. A) Representative image of 
livers f female Wistar rats used as control (left panel) and rats HCC (right panel) which 
were given diethylnitrosamine 50 mg/L ad libitum in their drinking water for a period of 
10 weeks. Scale bar, 10mm. B) Liver sections (HCC 14 weeks) were analyzed for Chk2 
and phospho-Histone H2A.X(Ser139) expression (see nuclear staining in the right 
panels, Scale bar 200µm.). C) and D) Five animals for each time point were sacrificed 
on week 4, 6, 8, 10, 14. Chk2 and phospho-Histone H2A.X(Ser139) expression were 
determined according to H-score method. The average positive percentage was 
calculated, and a H-score between 0 and 300 was obtained where 300 was equal to 
100% of tumour cells stained brown strongly. The positive cut off was considered ≥100. 
The levels of Chk2 and phospho-Histone H2A.X(Ser139) expression are indicated as 
fold increase of cut-off values.* P<0.001 vs 8 weeks. Chk2 expression was evaluated in 
the nucleus of the HCC tissue  as indicated by the brown staining. 
 
Figure 2a. Detection of Chk2 protein in human HCC by immunohistochemistry. 
Paraffin-embedded tissue sections were stained with a specific antibody for Chk2 and 
hematoxylin and eosin. A) Normal liver with a moderate, diffuse cytoplasmic Chk2 
staining. B) Chk2 immunoreactivity in cancer tissue from a tumour classified Grade 1  
characterized by a weak focal cytoplasmic Chk2 staining. C) and D) Chk2 
immunoreactivity in cancer tissue from a tumour classified Grade 2 with a strong Chk2 
perinuclear and  moderate nuclear accumulation.  E) Chk2 immunoreactivity in cancer 
tissue from a tumour classified Grade 3 with a clear and strong nuclear staining, without 
cytoplasmic and perinuclear Chk2  staining. Scale bar 100µm. 
 
Figure 2b. CHK2 Expression in HCC subtypes from TCGA database. 
CHK2 expression from RNA-seq data was retrieved for 101 patients with TP53 
mutations and  85 patients with CTNNB1/beta-catenin mutations, using the LIHC cohort 
of 377 cases (accessed on November 16, 2016). Patients with both TP53 and CTNNB1 
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mutations were excluded from the analysis. Expression levels are expressed as log2exp 
(absolute levels) or z-score (expression levels in HCC samples normalized to the 
expression levels in the reference population).Graph shows mean ± SEM, *p<0.0001 
 
 
Figure 3. Defective chromosome segregation  causes Chk2 overexpression in 
hTERT immortalized human hepatocytes. A) Examples of chromosome numbers 
from metaphase spreads of HCT116, Huh7 and HuS0gen cells (upper panels). In the 
bottom panels individual chromosome numbers percentage from metaphase spreads of 
HCT116, Huh7 and HuS0gen cells are represented (n=20). B) Representative 
immunoblot out of three independent experiments demonstrating the protein levels of 
Chk2 in indefinite cultured HCT116 and Huh7 cells, in HuS0gen cells and HuS0gen 
cells after 30 generations in culture (HuS30gen). C) Example of chromosomes from 
metaphase spreads of HuS30gen exhibiting numerical and structural (red arrow) 
alterations; the histogram shows individual chromosome numbers percentage in 
HuS30gen (n=20). D) Representative immunoblot out of three independent experiments 
demonstrating the protein levels of phospho-Histone H2A.X (Ser139), a hallmark of 
DNA damage,  in indefinite cultured   HCT116, Huh7,  HuS0gen  and HuS30gen cells. 
 
Figure 4. Chk2 overexpression is linked to lagging chromosomes. A) Chk2 co-
localizes with chromosomal structures only in HuS30gen cells. Asynchronously growing  
HCT116, Huh7, HuS0gen and HuS30gen cells  were synchronized in metaphase by 
releasing cells  from  thymidine treatment into MG132. Metaphase mitotic  spindles  
were monitored by immunofluorescence and typical examples are given,   endogenous 
Chk2 (red); kinetochores, CENP-H (green); chromosomes  are stained with Hoechst 
33342 (blue).   Chk2 co-localization with chromosome structures was quantified in 
metaphases (mean±SD; n≥ 300 metaphases)  B) HuS0gen that express low levels of 
protein Chk2  were stably transfected with HA-tagged Chk2 and asynchronously 
growing cells were evaluated for lagging chromosomes; typical examples of lagging 
chromosomes containing anaphase and telophase are given (HA-Chk2, red; CENP-H, 
green; chromosomes, Hoechst 33342, blue). C) Asynchronously growing HuS30gen 
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cells expressing H2B-GFP (to visualize in vivo  lagging chromosomes) were analyzed 
by live cell microscopy. Left, phase-contrast images; middle, fluorescence images; right, 
merge. Scale bar, 10 µm. D) Asynchronously growing cells, HCT116, Huh7, HuS0gen,  
HuS30gen, and  HuS0gen stably transfected with HA-tagged Chk2 (HuS-Chk2) were 
stained with CENP-H (constitutive component of kinetochores) and Hoechst 33342 
(chromosomes). Anaphase and telophase lagging chromosomes were counted by 
immunofluorescence, (mean ± SD; n= 500 cells) *p<0.01 vs HuS0gen. **p<0.05 vs 
HuS-mock 
 
Figure 5. Overexpressed/phosphorylated Chk2 is correlated with increased 
chromosomal missegregation. A) HuS30gen cells were stably retrovirally-transduced 
either with a control shRNA (shCTL) or shRNAs  targeting CHK2 (shChk2). Chk2-
depleted HuS30gen cells were used to reconstitute expression of CHK2 by introducing 
a shRNA resistant mutant of CHK2 (myc-Chk2resist). The protein levels were 
determined by immunoblotting and a representative example is shown. B) 
Asynchronously growing cells HuS30-shCTL, HuS30-shChk2 and Chk2-depleted 
HuS30gen reconstituted with shRNA resistant mutant of CHK2 were stained with 
CENP-H (kinetochores) and Hoechst 33342 (chromosomes). Anaphase and telophase 
lagging chromosomes counted by immunofluorescence, (mean ± SD; n= 500 cells), *p < 
0.01vs controls. C) The mitotic index of asynchronously growing cells HuS30-shCTL, 
HuS30- shChk2 and Chk2-depleted HuS30 reconstituted with shRNA resistant mutant 
of CHK2 was measured by counting the mitotic figures (prophase, metaphase, 
anaphase, and telophase) positively stained for phosphorylated histone H3 (pHH3).The 
mitotic index was calculated as percentage of mitotic cells/total cells as described in 
Materials and Methods. Error bars show the SD from the means of three independent 
experiments, *p<0.01vs controls. D)  Chk2 phosphorylation levels on Thr68 and Thr387. 
Representative immunoblot out of three showing asynchronously growing HCT116, 
HuS0gen, HuS30gen, and HuS0gen stably  transfected with Chk2 (HuS-Chk2). Cell  
lysates  were immunoblotted against p-Thr68-Chk2 and p-Thr387-Chk2. E) Activated 
Chk2 localizes with mitotic structures in HuS30gen cells. Example of metaphase, 
anaphase and telophase from unstable HuS30gen cells  and stable HCC cell line, 
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Huh7. Activated Chk2 (p-Thr68-Chk2, red) co-localizes with CENP-H, constitutive 
component of kinetochores (green) only in HuS30gen. Arrowheads indicate lagging 
chromosomes,  (Hoechst 33342, blue). Scale bar, 10 µm.   
 
Figure 6. Up-regulated Chk2 cooperates with  Aurora B for chromosome 
condensation and cytokinesis 
A)HuS0gen cells showing expression and localization of endogenous Chk2 (red),   
Aurora B kinase (green), and chromosomes (Hoechst 33342, blue) B) Co-localization of 
Aurora B kinase (green) with HuS0gen  overexpressing  HA-tagged Chk2 (red) in  
mitoses with lagging chromosomes (Hoechst 33342, blue). Cells were fixed and 
analyzed by fluorescence microscopy. Arrows indicate spindle midzone region, 
arrowheads indicate midbody region. C) HuS0gen cells overexpressing HA-tagged 
Chk2 were stained with antibody anti-HA (red) and phospho-Histone H3 (green) to show 
co-localization of Chk2 with missegregating chromosomes. Scale bar, 10 µm. 
 
 
Figure 7.  FHA domain is essential for Chk2 localization and contributes to 
sustain   lagging chromosomes. Red fluorescent protein was conjugated at the N-
terminus of each Chk2 mutant. Left, schematic diagrams. RFP was omitted. RFP-Chk2 
mutants were transfected in HuS30gen cells, synchronized and blocked in metaphase 
by treatment with MG132 for 2 hours, the cells were analyzed by fluorescence 
microscopy. A) Expression and subcellular localization of RFP-Chk2. RFP-Chk2 
decorates the spindle poles (two red dots), and localizes with kinetochores (CENP-H, 
green), chromosomes are stained with Hoechst 33342, blue. B) RFP-Chk2D347A, 
kinase dead mutant (KD), localizes similarly to RFP-Chk2. C) RFP-Chk2∆FHA does not 
localize to mitotic structures. D) RFP-FHA localizes to spindle poles, kinetochores. FHA 
domain tagged with RFP is similar to RFP-Chk2. Scale bar, 10 µm. E) Quantification of 
lagging chromosomes during anaphases and telophases  in HuS0gen  cells stably  
expressing Chk2(KD), Chk2∆FHA and Chk2FHA mutants.  Chk2 FHA mutant   
significantly reduces  the number of lagging chromosomes as a result of   the  dominant 
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negative effect    towards  endogenous Chk2. mean±SD; n=400 anaphases and 
telophases. *p<0.01vs control 
 
Figure 8. P53 and phosphorylated Rb expression in HCT116, HuS30gen and 
HuS0gen. A) Representative immunoblot out of three showing the protein levels of p53 
in HCT116, Huh7, HuS30gen and HuS0gen cells. In the same blot are represented p53 
expression levels of HuS0gen cells after treatment with DNA-damaging agent 5-
fluorouracil (5-FU, 1µM). B) Representative images of HCT116, Huh7 and HuS30gen 
cells fixed and stained with an antibody directed against  the mutated codon TGT at  
position 220  of  p53 protein. Huh7 cells,   previously characterized  as p53 mutated 
(see reference 30),   are used as positive control. C) Representative immunoblot out of 
three independent experiments showing the protein levels of Rb and phosphorylated 
Rb, p-Rb (Ser807/811), in HCT116, HuS30gen and HuS0gen cells. D), E) and F) 
Mitoses of asynchronously growing HCT116, HuS30gen and HuS0gen cells stained 
with the  antibody specific for phosphorylated Rb and analyzed by fluorescence 
microscopy; p-Rb (Ser807/811) red; chromosomes (Hoescht 33342,  blue). Scale bar, 
10 µm.  
 
Figure 9. A proposed schema  illustrating the mechanism by which Chk2 
overexpression  and mislocalization sustains  defective mitoses throughout hepatic 
tumorigenesis. Mitotic errors  represented by lagging chromosomes cause DNA 
damage and  overexpress   Chk2  in  genetically unstable cells. Chk2  and 
phosphorylated forms of Chk2 mislocalize within the mitotic structures in the presence 
of DNA damage contributing to increase the  numbers of  lagging chromosomes.  
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Figure 2b  
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Table 1. Patients and Tumor Characteristics (Florence Cohort) 
    
Age 
 
   <60 years                                                 35 
                                     
   
   ≥60 years                                                 14    
Gender 
  
   Male                                                         37  
                   
   Female                                                     12 
   
 
 
Etiology of  the  liver disease 
   
 
  HCV *                                                        28 
 
  HBV †                                                          6 
 
  NBNC ‡                                                     15 
   
 
Tumor size 
 
  ≤ 5 cm                                                      44 
 
  ≥ 5 cm                                                        5 
   
    
Cirrhosis  
 
  Yes                                                           47 
 
  No                                                              2 
 
   
Tumor numbers    
  Single                                                       46    
  Multiple                                                      3    
    
* HCV: hepatitis C virus 
†  HBV: hepatitis B virus 
‡ NBNC: non-hepatitis B, non-hepatitis C 
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HCC grade           n                       Chk2neg                            Chk2pos            P value 
 
      II                     16                     11 (68.7%)                 5 (31.3%)         < 0.001 
 
 
     III                     33                      7 (21.2%)                26 (78.8%) 
 
 
 
 Total                     49                    18 (36.8%)               31 (63.2%) 
 
Table 2. Chk2 nuclear  expression in human HCCs  (Florence cohort) and its association  with 
tumor grade. Chk2 expression   was evaluated in various HCC grades and the correlation of 
specimens with high Chk2 was measured (Two-tailed Fisher’s exact test) 
Page 66 of 79
https://mc.manuscriptcentral.com/gut
Gut
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
 
Table 3. Patients and Tumor Characteristics (Royal Free Cohort) 
    
Age 
 
<60 years                                               9 
 
   
≥60 years                                              11    
Gender 
 
Male                                                      19 
 
Female                                                   1 
   
 
 
Etiology of  the  liver disease 
   
 
HCV *                                                      6 
 
HBV †                                                      2 
 
NBNC‡                                                   12 
   
 
Tumor size 
 
≤ 5 cm                                                    15 
 
≥ 5 cm                                                     5 
   
    
Cirrhosis  
 
Yes                                                          9 
 
No                                                          11 
 
   
Tumor numbers    
Single                                                     14    
Multiple                                                    6    
    
*HCV: hepatitis C virus 
†  HBV: hepatitis B virus 
‡NBNC: non-hepatitis B, non-hepatitis C 
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Table 4. Chk2 nuclear  expression in human HCCs (London cohort) and its association  with 
tumor grade. Chk2 expression   was evaluated in various HCC grades and the correlation of 
specimens with high Chk2 was measured (Two-tailed Fisher’s exact test)                                                                                                                                                                          
 
 
 HCC grade             n                               Chk2neg                          Chk2pos          P value 
 
        I                      3                                 3                           0                
 
       II                    12                                 8                           4               <0.05 
 
       III                     5                                 0                           5 
  Total                    20                               11                          9 
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Cell cultures and antibodies. HCT116, Huh7 were from ATCC. Human hepatocytes 
immortalized with TERT gene (HuS) were provided by Makoto Hijikata (Laboratory of 
Human Tumor Viruses, Institute of Virus Research, Kyoto University, Japan). HCT116 and 
Huh7 were grown in DMEM medium supplemented with 10% fetal bovine serum, 1% 
penicillin/streptomycin and 1% glutamine at 37°C and 95%humidity and 5% CO2. HuS 
cells were cultured in DMEM medium supplemented with 5% fetal bovine serum, 5% 
normal human serum from male type AB serum (Sigma), 1% DMSO, 0.1µL/mL insulin, 
0.1µL/mL hydrocortisone and 2 ng/mL EGF (Calbiochem). Antibodies employed were anti-
Chk2 (Cell Signaling, #3440), anti-phospho-Thr68-Chk2 (Cell Signaling, #2661), anti-
phospho-Thr387-Chk2 (Cell Signaling, #2668), anti-Nek2 (Santa Cruz Biotechnology, 
sc#55601), anti-γ-tubulin (Santa Cruz Biotechnology, sc#7396-R), anti-CENP-H (Santa 
Cruz Biotechnology, sc#22792), anti-phospho-Histone H3(Ser10) (Cell Signaling, #9701), 
anti-phospho-Rb(Ser807/811) (Cell Signaling, #8516), anti-p53 (Santa Cruz 
Biotechnology, Clone Pab240, sc#99), anti-Aurora B kinase (Sigma,#A5102), anti-β-actin 
(clone AC-15) (Sigma-Aldrich). Secondary antibodies conjugated to AlexaFluor 488 and 
594 (Molecular Probes) were used in immunofluorescence analysis. Secondary antibodies 
used in immunoblot analysis were, IRDye 800CW anti-rabbit (#926-32210, Lycor 
Bioscience, Lincoln, NE) and IRDye 800CW anti-mouse (#926-32211, Lycor Bioscience). 
DNA was stained with Hoechst 33342 (ThermoScientific). 
 
Karyotype analysis. Cells were plated on Slideflask 50-70% confluent. For cell-cycle 
synchronization, cells were blocked twice with 2 mM thymidine (Sigma) and released into 
the medium. For synchronization at metaphase, cells were released from thymidine for 6 
hours, followed by treatment with MG132 (20 µM; Calbiochem) for an additional 2 h. The 
culture medium was removed and a hypotonic solution (0,56% potassium chloride, 0,50% 
sodium citrate tribasic dehydrate) was added and incubated for 10 mins at room 
temperature (RT). The hypotonic solution was removed and a pre-fix solution (acetic acid 
0,5%) for 10 mins at RT was added. Next, a fixative solution (acetic acid/ ethanol) was 
added for 10 mins. The metaphase spread chromosomes were stained with Giemsa for G-
banding and analyzed with Zeiss Axioplan 2 microscope. 
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Western blot analysis 
Standard procedures were used. Briefly, protein lysates were quantified by the Bradford 
method (Bio-Rad, Hercules, CA) and fifty micrograms of total protein were denaturated 
and separated on MiniProtran TGX precast gels (Bio-Rad). After separation, the proteins 
were electroblotted to nitrocellulose membranes with semidry Trans-Blot (Bio-Rad) and 
successively membranes were incubated in a blocking solution consisting of phosphate 
buffered saline (PBS)/Odyssey Blocking Buffer 1:1 (PBS/OBB) (Lycor Bioscience) for 1 
hour at room temperature. Membranes were then incubated overnight at 4°C with the 
appropriate antibody, washed four times with PBS-Tween 0.1% solution, and probed with 
the secondary IRDye antibodies according to the manufacturer’s instructions. The protein 
bands were analysed by the Odyssey Infrared Imaging System (Lycor Bioscience) using 
software for protein quantification. 
 
Retroviral infections. The following shRNAs (OriGene Technologies) were stably delivered 
into Hus cells by retroviral infection according to manufacturer’s instructions.TF320655 is a 
set of plasmids containing four shRNA constructs in retroviral vector (pRFP-C-RS) to 
knockdown human CHK2. TR30015 is a non-effective 29mer scrambled shRNA used as 
control. Retroviral particles were generated by transient transfection of the Phoenix-
amphotropic packaging cell line as previously described. Phoenix cells plated onto 100mm 
dishes were transfected at approximately 80% confluence with 20 µg of plasmid using 
Lipofectamine 2000 transfection reagent. After 48 hours, virus-containing supernatant was 
recovered and centrifuged, filtered (0.45µm filters) and used immediately or aliquoted and 
frozen at -80°C. Target cells were infected with virus-contain ng supernatant in the presence 
of polybrene (8µg/ml, Sigma). Retrovirally infected Hus cells were selected in puromycin-
containing medium and, after 2 weeks, reduced expression of Chk2 protein was assessed by 
immunoblotting. A shRNA resistant mutant of CHK2 was generated using the mutagenesis kit 
(QuikChange; Agilent Technologies) yielding an exchange of four bases within the shRNA 
targeting sequence (5'-GCTCCTTAGAGACAGTGTCCACTCAGGAA-3') without changing the 
resulting amino acid sequence and cloned into the pcDNA3.1 plasmid. 
 
Expression of Chk2 mutants. The plasmid pBabe-HA tagged Chk2 (Addgene) coding for 
full length human CHK2 was used as template to clone Chk2 into pTagRFP-C1 (Evrogen) 
plasmid by PCR and the construction of a kinase dead mutant (D347A) by site-directed 
mutagenesis primer sense 
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 5'-AACGGTATTATACACCGTGCATTAAAGCCAGA-3'. To generate plasmid RFP-
Chk2∆FHA coding a Chk2 protein lacking the FHA domain, a fragment containing amino 
acids 1–112 of Chk2 was isolated by PCR from pBabe-HA tagged Chk2 and cloned as a 
XhoI-EcoRI fragment into the pTagRFP-C1 vector. A second fragment containing amino 
acids 201-342 isolated by PCR was cloned in frame using PstI-KpnI into the vector 
pTagRFP-C1 harbouring the fragment 1-112. To produce RFP-Chk2FHA plasmid the XhoI 
and BamHI-flanked fragment containing the FHA domain was cloned from pBabe-HA 
tagged Chk2 into the pTagRFP-C1vector. 
 
Immunofluorescence and live-cell microscopy. Cells were fixed in ice-cold methanol 
for 5 min at -20°C, washed twice with PBS at RT, blocked 60 minutes in 3% BSA with 
0.05% NP-40 and immunostained. HuS cells were transfected with H2B-GFP (Addgene) 
and seeded onto Petri dishes with a 35-mm glass bottom (Ibidi). Phase-contrast and 
fluorescence images were taken by using an inverted fluorescence microscope (DMIRE2; 
Leica) and a 40X Plan Neo 0.6 NA Ph2 objective. Live imaging was performed in air, at 
37°C in 5% CO2, using a camera (DFC300FX; Leica) and IM50 acquisition software 
(Leica). 
 
Mitotic index. Cells were fixed in ice-cold methanol for 5 min at -20°C, washed twice with 
PBS at RT, blocked 60 minutes in 3% BSA with 0.05% NP-40, stained with antibody 
against pHH3 (Ser10) and Hoechst 33342 for DNA. Ten high-power fields were examined 
by fluorescence microscopy, mitotic figures (profase, metaphase, anaphase, and 
telophase) were counted and mitotic index was calculated as percentage of mitotic green 
cells(pHH3)/total blue cells (Hoechst). 
 
 
Statistical analysis. The significance of correlations between CHK2 expression patterns 
in human tissue and grade was measured by applying two-sided Fisher’s exact test. All 
quantifications of mitotic indexes and lagging chromosomes were based on at least 3 
independent experiments, in which at least 500 mitotic figures were evaluated. The data 
are expressed as means±SD. Statistical analysis was performed by two-tailed Student's t-
test. 
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Ethical Approval for Use of Human Material and Animal Experimentation. Informed 
written consent was obtained from all patients in accordance with the guidelines of 
University Hospital of Florence and Royal Free Hospital, London. All animal experiments 
were approved and performed in accordance with the regulations set forth by the Italian 
Ministry of Health. 
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SUPPLEMENTARY  LEGENDS 
Figure S1. H-score examples (range 0 to 300). Case (A) weak Chk2 expression; H-
score 20. Case (B) moderate Chk2 positive; H-score 150. Case (C) remarkable Chk2 
expression; H-score 230. Case (D) strong Chk2 expression; H-score 300.  Scale bar, 100 
µm. 
 
Figure S2. Detection of Chk2 protein in different histotype of human HCC.  A) Normal 
liver negative control (sections treated with nonimmune antibody), B) Normal liver showing 
a faint cytoplasmic staining of  Chk2  without nuclear detection, C) HCC pseudo-glandular 
histotype negative control (sections treated with nonimmune antibody), D) HCC pseudo-
glandular histotype with nuclear expression of Chk2, E) HCC trabecular histotype negative 
control, F) HCC trabecular histotype showing strong nuclear Chk2 expression, G) HCC 
scirrhous histotype negative control, H) HCC scirrhous histotype with the scattered cancer 
cells showing nuclear staining for Chk2. Scale bar, 100 µm. 
 
Figure S3. A) Vascular invasion of a cluster of HCC cells showing Chk2 nuclear 
staining (100x magnification). B) inset shows the presence of a cell with lagging 
chromosomes (250x magnification). 
 
 
 Figure S4. G-banding images of  chromosome spreads and Chk2  localization 
through mitotic phases  in HuS30gen cells.  A) The chromosomes of metaphase 
spread of HuS30gen exhibit numerical and structural (red arrows) abnormalities. B) 
HuS30gen cells were synchronized by thymidine treatment and then released into 
medium. Bipolar spindle assembly and chromosome alignment were monitored by 
immunofluorescence and typical examples are given,   endogenous Chk2 (green), γ-
tubulin (red), chromosomes  are stained with Hoechst 33342 (blue). 
 
 
Figure S5.  Nek2 interactions with mitotic structures in HCT116, Huh7, HuS0gen and 
HuS30gen. A) Representative immunoblot out of three independent experiments showing 
the Nek2 protein expression in indefinite cultured HCT116 and Huh7 cells, or in HuS0gen 
and HuS30gen cells, *p ≤0.001 vs HCT116 or Huh7. B) Nek2 localization in metaphase 
blocked HCT116 and Huh7 cells. Nek2 (arrows) localizes with poles of mitotic spindle in 
both cell lines (Nek2, red; γ-tubulin, green; chromosomes, bleu). C) HuS0gen  and 
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HuS30gen were synchronized and blocked in metaphase. Representative image  of  Nek2 
(arrow)  localization in HuS0gen and HuS30gen (Nek2, green; γ-tubulin, red; 
chromosomes, bleu). Both cell lines show low expression levels of Nek2 protein. Scale 
bar, 10 μm.   
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